Network origin in Henri A. Termeer first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.
206
| Subsidiary | Medical Specialties | 206 |
| Subsidiary | Medical Specialties | 45 | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC.
34
| Non-Profit Organization | Pharmaceuticals: Major | 34 |
| Subsidiary | Pharmaceuticals: Major | 25 | |
| Subsidiary | Pharmaceuticals: Major | 22 | |
| Public Company | Biotechnology | 19 | |
| Public Company | Pharmaceuticals: Major | 18 | |
Lysosomal Therapeutics, Inc.
 Lysosomal Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Lysosomal Therapeutics, Inc. engages in the innovation, research, and development in the field of neurodegeneration. It focuses in lysosomal biology in developing novel small molecules for use in the treatment of neurodegenerative diseases. The company was founded by Dimitri Krainc, Joseph Mazzulli, Henri A. Termeer, Robert J. Carpenter, Peter Wirth, Edmund J. Sybertz, and Kees Cornelis Been in 2011 and is headquartered in Cambridge, MA.
13
| Extinct | Pharmaceuticals: Major | 13 |
| Public Company | Biotechnology | 11 | |
Federal Reserve Bank of Boston
9
| Government | General Government | 9 |
ModernaTX, Inc.
 ModernaTX, Inc. BiotechnologyHealth Technology Modernatx, Inc. develops messenger RNA therapeutics. Its vivo drug technology that produces human proteins, antibodies and entirely novel protein constructs inside patient cells, which are in turn secreted or active intracellularly. The company was founded by Derrick J. Rossi, Doug G. Cole, Doug G. Cole, Robert S. Langer, Jr., Noubar Afeyan, and Kenneth R. Chien in 2011 and is headquartered in Cambridge, MA.
5
| Subsidiary | Biotechnology | 5 |
New England Healthcare Institute
 New England Healthcare Institute Miscellaneous Commercial ServicesCommercial Services New England Healthcare Institute operates as a national nonprofit, nonpartisan organization composed of stakeholders from across all key sectors of health and health care. The company was founded by Henri A. Termeer in 2002 and is headquartered in Boston, MA.
3
| Non-Profit Organization | Miscellaneous Commercial Services | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Henri A. Termeer via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| University of Massachusetts | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Graduate Degree Masters Business Admin | |
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Chief Executive Officer Corporate Officer/Principal | |
European Federation of Pharmaceutical Industries & Assns
 European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member President Director/Board Member | |
| PFIZER, INC. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal Chairman Corporate Officer/Principal | |
| AURA BIOSCIENCES, INC. | Biotechnology | Director of Finance/CFO Director/Board Member Chief Operating Officer Director of Finance/CFO | |
| Tufts University | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| KARYOPHARM THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member Founder Founder Director of Finance/CFO | |
| VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Founder Corporate Officer/Principal Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
Tvardi Therapeutics, Inc.
 Tvardi Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tvardi Therapeutics, Inc. develops and commercializes medicines for the treatment of diverse cancers, chronic inflammatory and fibrotic diseases. The company was founded by David J. Tweardy and Ronald A. DePinho in 2017 and is headquartered in Houston, TX. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Consultant / Advisor Founder | |
Sporos Bioventures, Inc.
 Sporos Bioventures, Inc. Medical/Nursing ServicesHealth Services Sporos Bioventures, Inc. is a private biopharmaceutical company based in Houston, TX. Sporos Bioventures, Inc. aims to transform the drug development process by identifying novel disease mechanisms and strategically deploying talent, capital, and access to operational resources to catalyze the development of breakthrough medicines. Sporos' current pipeline is diversified across three business units and includes multiple clinical-stage candidates that are being investigated for the treatment of multiple indications in cancer and immune disease. The company provides centralized expertise, resources, and core infrastructure so that the portfolio companies can focus primarily on their research development programs. The company was founded by Peter Feinberg, Ronald A. DePinho, Jeno Gyuris, Joseph Kekst, Harold Levy, Alex M. Cranberg, Louis Feinberg, Michael S. Wyzga, Dana Levy, and the CEO is Stephen Rubino. | Medical/Nursing Services | Founder Chief Executive Officer Founder Founder | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
International Federation of Pharmaceutical Manufacturers
 International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | Biotechnology | Director/Board Member Director/Board Member President President | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| US Military Academy | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| Columbia Law School | College/University | Graduate Degree Graduate Degree Graduate Degree Graduate Degree | |
| University of Pennsylvania | College/University | Graduate Degree Undergraduate Degree Doctorate Degree | |
Massachusetts Medical Device Industry Council
 Massachusetts Medical Device Industry Council Miscellaneous Commercial ServicesCommercial Services Massachusetts Medical Device Industry Council, also known as MassMEDIC, is the largest regional medtech association in Massachusetts. With over 300 members, the organization represents manufacturers, product developers, suppliers, research institutions, and academic health centers. | Miscellaneous Commercial Services | Chairman Chairman Director/Board Member | |
Biogen MA, Inc.
 Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Integrated Genetics, Inc.
 Integrated Genetics, Inc. Pharmaceuticals: MajorHealth Technology Part of Laboratory Corp. of America Holdings, Integrated Genetics, Inc. is a pharmaceutical preparations company. The company is based in Framingham, MA. The company was founded by Robert J. Carpenter. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Executive Officer Corporate Officer/Principal | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Chairman Corporate Officer/Principal | |
| DYAX CORP. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO Corporate Officer/Principal | |
| Harvard Medical School | College/University | Doctorate Degree Doctorate Degree Corporate Officer/Principal | |
| GSK PLC | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer Comptroller/Controller/Auditor | |
| SANOFI | Biotechnology | Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal | |
CEO Roundtable on Cancer, Inc.
 CEO Roundtable on Cancer, Inc. Miscellaneous Commercial ServicesCommercial Services CEO Roundtable on Cancer, Inc. promotes activities to reduce cancer risk, enable early detection, facilitate better access to treatment and hasten the discovery. Its programs include CEO cancer gold standard, life sciences consortium and project data sphere. The company was founded by George H. W. Bush in 2001 and is headquartered in Durham, NC. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
| Dartmouth College | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| BLUEBIRD BIO, INC. | Biotechnology | General Counsel Director of Finance/CFO Comptroller/Controller/Auditor | |
| CUBIST PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
Impatients NV
 Impatients NV Miscellaneous Commercial ServicesCommercial Services Impatients N.V. operates an online platform for drug innovations. It provides physicians and patients that are excluded from clinical trials access to drugs in development via early access programs. The company was founded by Ronald Brus, SJaak Vink, Govert J. Schouten, Witt Jan, Erdem Yavuz, and René Beukema in 2012 and is headquartered in Amsterdam, the United Kingdom. | Miscellaneous Commercial Services | Founder Director/Board Member Chairman | |
Asylia Therapeutics, Inc.
 Asylia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Asylia Therapeutics, Inc. is a private biotechnology company founded in 2019 by Richard Jones, Robert Z. Orlowski, and Ronald A. DePinho. The company is based in Houston, TX. Asylia Therapeutics is focused on developing novel immune modulating therapies for cancer and autoimmune diseases. The company's drug pipeline is capable of modulating antigen presentation to the immune system, which has produced anti-tumor responses across multiple cancer models. The company is supported by a $3 million grant from the Cancer Prevention & Research Institute of Texas. The CEO is Karthik Radhakrishnan. | Pharmaceuticals: Major | President Chief Tech/Sci/R&D Officer Founder | |
The Business Roundtable
 The Business Roundtable Miscellaneous Commercial ServicesCommercial Services The Business Roundtable advocates public policies that ensure economic growth. It considers public policy issues which contains groups like the construction users anti-inflation roundtable, a group devoted to containing construction costs; and the labor law study committee, made up of labor relations executives of major companies. The Business Roundtable was founded in 1972 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member Chief Executive Officer | |
Metamark Genetics, Inc.
 Metamark Genetics, Inc. Medical/Nursing ServicesHealth Services Metamark Genetics, Inc. provides molecular diagnostics services. It develops prognostic and predictive diagnostic tests that will enable personalized treatment planning for cancer patients. It transforms cancer diagnosis and treatment by developing pioneering diagnostic products based on its prognosis determinants platform. The company was founded by Kenneth E. Weg, Raju S. Kucherlapati, David Rimm, Lynda Chin and Ronald A. DePinho in November 2007 and is headquartered in Waltham, MA. | Medical/Nursing Services | Founder Director/Board Member Founder | |
| Boston College | College/University | Director/Board Member Undergraduate Degree Undergraduate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree | |
| MODERNA, INC. | Biotechnology | Founder Corporate Officer/Principal Director of Finance/CFO | |
| Suffolk University | College/University | Undergraduate Degree Masters Business Admin Masters Business Admin | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Doctorate Degree | |
Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC
 Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC Miscellaneous Commercial ServicesCommercial Services Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC provides legal services. The firm offers services to the communications, education, environmental, health, immigration, public finance, real estate and tax industries. The company was founded in 1933 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| Millennium Predictive Medicine, Inc. | Founder Founder | ||
| PORTOLA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| EXACT SCIENCES CORPORATION | Medical Specialties | Director/Board Member Director/Board Member | |
| Perelman School of Medicine | College/University | Doctorate Degree Doctorate Degree |
Statistics
International
| United States | 45 |
| Netherlands | 3 |
| Belgium | 2 |
| Switzerland | 2 |
| United Kingdom | 2 |
Sectoral
| Health Technology | 25 |
| Consumer Services | 13 |
| Commercial Services | 10 |
| Health Services | 3 |
| Finance | 3 |
Operational
| Director/Board Member | 720 |
| Corporate Officer/Principal | 260 |
| Independent Dir/Board Member | 183 |
| Chairman | 163 |
| Chief Executive Officer | 109 |
Most connected contacts
| Insiders | |
|---|---|
| Antoine Papiernik | 48 |
| Douglas Cole | 44 |
| Nicholas G. Galakatos | 38 |
| Christopher Viehbacher | 37 |
| Trevor Jones | 36 |
| Jeffrey Aronin | 35 |
| Louis Lavigne | 32 |
| Ambrose Bailey | 32 |
| Michael Wyzga | 31 |
| Richard H. Aldrich | 31 |
| Russell C. Hirsch | 31 |
| Ian Read | 29 |
| Cathy Minehan | 27 |
| David Pyott | 27 |
| John Lechleiter | 26 |
- Stock Market
- Insiders
- Henri A. Termeer
- Company connections
